Ventricular tachycardia - Nursing Case Study

Pathophysiology

• Primary mechanism: Abnormal electrical pathways or circuits in the ventricles, often due to myocardial scarring from previous heart damage, lead to rapid and disorganized ventricular contractions, reducing effective cardiac output.

• Secondary mechanism: Enhanced automaticity in ventricular cells causes spontaneous depolarization, contributing to the initiation and maintenance of ventricular tachycardia, particularly in conditions like ischemia or electrolyte imbalances.

• Key complication: The rapid heart rate can lead to decreased ventricular filling time and compromised coronary perfusion, potentially progressing to hemodynamic instability, syncope, or sudden cardiac arrest if not promptly managed.

Patient Profile

Demographics:

58, male, construction worker

History:

• Key past medical history: Hypertension, Coronary artery disease

• Current medications: Metoprolol, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Palpitations and dizziness

• Key symptoms: Shortness of breath, chest discomfort, lightheadedness

• Vital signs: Blood pressure 90/60 mmHg, heart rate 150 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

Shortly after the initial assessment, the patient's condition began to deteriorate. The nurse noted a progressive decline in mental status; the patient became increasingly confused and lethargic, indicating possible cerebral hypoperfusion. His blood pressure dropped further to 80/55 mmHg, and his heart rate remained at 150 bpm despite the administration of an initial bolus of intravenous fluids. Tachypnea persisted with a respiratory rate of 26 breaths per minute, and his oxygen saturation decreased to 88% on room air, necessitating the initiation of supplemental oxygen therapy.

As the patient's hemodynamic status worsened, a 12-lead ECG was obtained, confirming the presence of a wide-complex tachycardia consistent with ventricular tachycardia. The clinical team began to suspect that the patient might be experiencing an acute exacerbation of his coronary artery disease, potentially precipitated by the reduced cardiac output and subsequent myocardial ischemia. This suspicion was reinforced by the patient's increasing chest discomfort and the presence of new ST-segment changes on the ECG.

Laboratory results soon returned, revealing elevated cardiac troponin levels, suggesting myocardial injury. Additionally, the patient's potassium level was found to be slightly low at 3.2 mEq/L, which could be contributing to the arrhythmia. Given the evolving clinical picture, the decision was made to prepare for synchronized cardioversion, while simultaneously correcting the electrolyte imbalance and optimizing the patient's hemodynamic status with vasopressors. The team recognized the urgency to restore an effective cardiac rhythm to prevent further complications, such as progression to ventricular fibrillation or cardiogenic shock, underscoring the critical nature of timely intervention in this unstable patient.

Section 2

As the team prepared for synchronized cardioversion, the nurse closely monitored the patient's response to the interventions initiated. The administration of vasopressors resulted in a modest improvement in blood pressure, now reading at 90/60 mmHg, offering a slight reprieve in cerebral perfusion and mental status. However, the patient still exhibited signs of confusion and lethargy, suggesting that the cerebral hypoperfusion had not fully resolved. Continuous ECG monitoring showed persistent wide-complex tachycardia, emphasizing the need for rapid cardioversion to stabilize the patient's condition.

Despite the partial stabilization, new complications began to emerge. The patient's respiratory status deteriorated further, with oxygen saturation dropping to 85% despite supplemental oxygen. Inspiratory crackles were auscultated bilaterally, raising concerns about potential pulmonary edema secondary to the heart's reduced pumping efficiency. The team quickly assessed the possibility of fluid overload due to the aggressive fluid resuscitation and adjusted the strategy to include diuretics to alleviate the pulmonary congestion. The patient's potassium level was also addressed with intravenous potassium replacement, cautiously monitored to avoid overcorrection, which could lead to other arrhythmic complications.

In the midst of these interventions, the patient's condition remained precarious, highlighting the intricate balance required to manage the competing demands of maintaining adequate perfusion while addressing the cardiac arrhythmia and potential heart failure. This complex scenario underscored the importance of clinical reasoning in dynamically adjusting the treatment plan to address both existing and emerging complications, setting the stage for the next critical phase in the patient's care journey.

Section 3

The patient's condition took another turn as the team observed an alarming change in the patient's status. Despite the administration of diuretics, the patient's respiratory distress intensified, with oxygen saturation now plummeting to 80%, necessitating the initiation of non-invasive positive pressure ventilation to support oxygenation. As the respiratory team worked to stabilize the patient, new diagnostic results were obtained, revealing a significant elevation in the patient's cardiac biomarkers. Troponin levels were markedly elevated at 0.35 ng/mL, suggesting myocardial stress or injury likely exacerbated by the persistent ventricular tachycardia and compromised myocardial perfusion.

The nurse noted that the patient's heart rate remained elevated at 160 beats per minute, with continuous wide-complex tachycardia on the ECG. Blood pressure showed further instability, dropping to a concerning 82/54 mmHg despite the vasopressor support. These findings indicated a potential progression to cardiogenic shock, characterized by the heart's inability to maintain adequate perfusion to vital organs. The patient's skin was cool and clammy, and capillary refill time was prolonged, reinforcing the clinical suspicion of worsening cardiac function.

In response to these developments, the team revisited the treatment strategy, considering the initiation of additional pharmacological support to enhance cardiac output and improve systemic perfusion. Discussions focused on the potential introduction of inotropes to augment myocardial contractility while carefully balancing the risks of exacerbating myocardial oxygen demand. The interprofessional team also deliberated the timing and approach for urgent cardioversion, recognizing the need to convert the arrhythmia to restore effective cardiac function. These critical decisions underscored the importance of timely clinical reasoning and the integration of evolving clinical data in managing the patient's complex and dynamic condition.

Section 4

As the team implemented non-invasive positive pressure ventilation and commenced inotropic support with dobutamine, the patient's condition remained precarious. Despite these interventions, the heart rate persisted at 160 beats per minute, and blood pressure continued to hover at a dangerously low level, with readings fluctuating between 78/50 mmHg and 84/52 mmHg. The persistence of wide-complex tachycardia on the ECG indicated that the arrhythmia had not yet been successfully managed, and myocardial perfusion remained severely compromised. The patient exhibited increasing signs of end-organ dysfunction, with altered mental status and decreased urine output, suggestive of progressing cardiogenic shock.

New diagnostic results were quickly obtained to further elucidate the evolving clinical picture. An arterial blood gas analysis revealed a pH of 7.28, pCO2 of 55 mmHg, and HCO3- of 18 mEq/L, indicating a mixed respiratory and metabolic acidosis. Lactate levels were elevated at 4.5 mmol/L, reflecting significant tissue hypoperfusion and anaerobic metabolism. These findings underscored the critical need for rapid intervention to restore adequate cardiac output and tissue oxygenation.

The interprofessional team, recognizing the gravity of the situation, convened to discuss the immediate next steps. The cardiology team proposed an urgent synchronized cardioversion to address the persistent ventricular tachycardia, aiming to restore sinus rhythm and improve hemodynamic stability. Concurrently, the possibility of an intra-aortic balloon pump was considered to provide mechanical support and enhance coronary perfusion. These strategic decisions highlighted the necessity for swift and coordinated action to stabilize the patient and prevent further deterioration. As the team prepared for these interventions, they remained vigilant, ready to respond to any new complications that might arise in the patient's complex clinical trajectory.

Section 5

As the team initiated synchronized cardioversion, the patient experienced a brief but significant improvement in rhythm and hemodynamics. The heart rate decreased to 90 beats per minute, and blood pressure improved to 100/65 mmHg, suggesting a transient stabilization. However, this positive response was short-lived. Within minutes, the patient reverted to ventricular tachycardia, with the heart rate accelerating back to 170 beats per minute. The blood pressure again plummeted to critical levels, now reading 76/48 mmHg. The patient's mental status deteriorated further, and he became unresponsive to verbal stimuli, raising immediate concerns about cerebral perfusion.

Simultaneously, the nurse at the bedside noted decreased peripheral pulses and mottled extremities, indicating worsening perfusion. The decreased urine output, now at 10 mL/hour, corroborated the ongoing decline in renal function, signifying advancing multi-organ dysfunction. New laboratory results showed an alarming increase in lactate levels to 6.0 mmol/L, underscoring the severity of tissue hypoxia and the need for urgent reevaluation of the treatment strategy.

In light of these developments, the interprofessional team swiftly reconvened. The cardiology team advocated for the immediate insertion of an intra-aortic balloon pump to augment cardiac output and coronary perfusion. Concurrently, the critical care team emphasized the potential need for escalation to advanced mechanical circulatory support if the intra-aortic balloon pump failed to stabilize the patient. As these critical interventions were being prepared, the team remained acutely aware of the need to monitor for any signs of further complications, ready to pivot their approach based on the ever-evolving clinical picture.